Associate Sales Representative, Capital Surgical Equipment - Minnesota
Baxter InternationalFull Time
Entry Level & New Grad, Junior (1 to 2 years)
Candidates should possess a Bachelor’s degree in a related field, along with at least 5 years of experience in sales, preferably within the healthcare or pharmaceutical industry. Strong knowledge of the oncology market, including molecular diagnostics, reimbursement, and competitive landscape is required, as well as proficiency in using Salesforce.com and Microsoft Office applications, particularly Excel and PowerPoint. Excellent negotiation and customer service skills, combined with the ability to handle sensitive information and maintain confidentiality, are essential.
The Clinical Account Executive will drive strategic business expansion and collaboration opportunities with cancer centers, oncology practices, and key opinion leaders within the assigned territory. They will structure strategic plans for gaining and retaining clients, maximize client-bill contracting opportunities, implement laboratory services agreements, and collaborate with other sales positions to achieve company goals. Responsibilities also include identifying and developing partnering opportunities, promoting compliance with new tools, analyzing the competitive landscape, developing a comprehensive business plan, and working effectively with individuals across multiple departments while maintaining a high level of market and customer knowledge. Frequent travel (over 50%) throughout the territory is required.
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.